Alpa Laboratories Limited has provided prior intimation of a scheduled Board of Directors meeting pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board meeting is scheduled for Saturday, November 14, 2026 at 2:00 PM. The primary agenda items include:
- Consideration and approval of the un-audited Standalone financial results for the quarter and half-year ending September 30, 2026
- Consideration and approval of the un-audited Consolidated financial results for the quarter and half-year ending September 30, 2026
- Any other items with the permission of the Chairman
The company has implemented a Trading Window closure for designated persons and their immediate relatives in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window closed on October 1, 2026 and will remain closed until 48 hours after the declaration of the un-audited financial results for the half-year ended September 30, 2026.
The disclosure serves as formal notification to BSE Limited and National Stock Exchange of India Limited for their records.